home Latest News UPDATE 1-IFR Americas ECM Pipeline – Reuters Africa

UPDATE 1-IFR Americas ECM Pipeline – Reuters Africa

This post was originally published on this site

(Adds Genpact blocl)

NEW YORK, Feb 12 (IFR) –


Virgin Trains USA (US, passenger rail) – $538.4 IPO. 28.3m shares (100% prim) at $17-$19. BARC, JPM, MS.


February 12 (PM): Genpact (US, BPO) – $326.2m Block. 10m shares (100% sec) at $32.40-$32.62 versus $32.62 last sale. GS.

February 12 (PM): MacroGenics (US, biotech) – $75m ABB. Fixed-sized (100% prim) at $19.75-$20.25 versus $20.99 last sale. SVBL, EVER.

February 13: 8×8 (US, telecom equipment) – $200m 5y CB talked at 0.5%-1%, up 27.5%-32.5%. MS.

February 13: TCR2 Therapeutics (US, biotech) – $80m IPO. 5m shares (100% prim) at $14-$16. JEFF, LEER, BMO. Nasdaq “TCRR”. Existing shareholders have indicated for up to $30m.

February 13: Avedro (US, medical devices) – $80m IPO. 5m shares (100% prim) at $14-$16. BAML, JPM. Nasdaq “AVDR”.

February 13: Cibus (US, ag biotech) – $106.7m IPO. 6.67m shares (100% prim) at $14-$16. MS, BAML, PJ.

February 13: Xeris Pharmaceuticals (US, biotech) – $73.5m FO. 5m shares (100% prim) versus $14.70 at launch. JEFF, RBC, MIZU.

February 14: Stealth BioTherapeutics (Cayman Islands, biotech) – $86.8m IPO. 6.2m shares (100% prim) at $12-$14. Nasdaq “MITO”. JEFF, EVER, BMO, NOM. Morningstar Venture Investments and associates have indicated interest in buying $60m of shares.

February 14: Watford Holdings (Bermuda, reinsurance) – Direct listing. JPM, BARC, MS. Nasdaq “WTRE”.


March: Hennessy Capital Acquisition IV (US, SPAC) – $250m IPO. 25m units (100% prim) to be marketed at $10.00. Each unit comprised of one share, three-quarters of a warrant. NOM, STIF.

The daily IFR US ECM Briefing covers US, Canadian and LatAM IPOs, as well as secondary and convertible offerings. Reporting By Robert Sherwood